BERKELEY, Calif.--(BUSINESS WIRE)--Indee Labs is a biotechnology company developing the µVS Delivery SystemTM for non-viral intracellular or gene delivery. The team at Indee Labs was recently awarded a contract from the National Cancer Institute to develop the µVS Delivery SystemTM for T cell immunotherapy discovery, development and manufacturing. "T cell immunotherapies have revolutionized how we treat disease; however, the processes to discovery, develop and manufacture these interventions ar
Indee Labs is a California-based biotechnology company that designs and manufactures non-viral intracellular delivery systems for life sciences companies.